Aether Industries Limited has announced its schedule of investor meetings for April 10, 2026, in compliance with regulatory requirements. The company filed the intimation with stock exchanges on April 4, 2026, outlining meetings with multiple institutional investors in Mumbai.

Meeting Schedule and Participants

The company has scheduled one-on-one physical meetings with five prominent institutional investors on April 10, 2026:

Regulatory Compliance

The investor meeting schedule has been submitted in accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time. This regulation mandates companies to inform stock exchanges about material events and information that could impact investor decisions.

Key Meeting Parameters

Aether Industries Limited has emphasized that no Unpublished Price Sensitive Information (UPSI) is intended to be discussed during these meetings. This ensures compliance with insider trading regulations and maintains transparency in investor communications. The company has also noted that the meeting schedule remains subject to change by either the investors or the company.

Corporate Information

The communication was signed by Chitrarth Rajan Parghi, Company Secretary & Compliance Officer (Mem. No.: F12563), and submitted to both BSE Limited and National Stock Exchange of India Limited. The company's registered office is located at Plot No. 8203, GIDC Sachin, Surat-394230, Gujarat, India.

Aether Industries Limited has completed the allotment of 5,454 equity shares under its Employee Stock Option Scheme 2021 (AIL ESOS 2021) on March 27, 2026. The Nomination and Remuneration Committee approved the issue and allotment to eligible employees who exercised their stock options.

Share Allotment Details

The equity shares were allotted with specific terms and pricing structure that reflects the company's employee benefit program.

Updated Share Capital Structure

Following the allotment, Aether Industries' share capital structure has been updated to reflect the additional equity shares issued under the ESOP scheme.

Regulatory Approvals and Compliance

The company has secured necessary regulatory approvals for its employee stock option scheme. Aether Industries obtained in-principle approval from BSE Limited and National Stock Exchange of India Limited for a pool of 11,00,000 equity shares under the AIL ESOS 2021 scheme.

The stock exchanges provided their approvals with the following details:

• NSE Filing: Application filed on October 6, 2022 (Filing No. NSE/LIST/32832), approved on November 11, 2022
• BSE Filing: Application filed on October 6, 2022 (Filing No. DCS/IPO/TL/ESOP-IP/2529/2022-23), approved on October 20, 2022

Share Characteristics and Trading

The newly allotted shares carry identical rights and privileges as existing equity shares. All shares issued under the scheme will rank pari-passu with existing equity shares, ensuring equal treatment for all shareholders. The company confirmed that no additional listing fees are required as it has already paid listing fees for issued share capital up to Rs. 200 crore for the current fiscal year.

The company will communicate this corporate action to depositories for crediting equity shares to beneficiaries' accounts, followed by obtaining listing and trading approvals from stock exchanges. The shares are identified by ISIN INE0BWX01014 and will be available for trading once the listing formalities are completed.